» Articles » PMID: 18185915

Morphology and Mechanical Behavior of TTCP-derived Calcium Phosphate Cement Subcutaneously Implanted in Rats

Overview
Publisher Springer
Date 2008 Jan 11
PMID 18185915
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

A pre-hardened, TTCP-derived CPC was immersed in Hanks' solution as well as subcutaneously implanted into abdomen of rats. The implant-soft tissue interfacial morphology was examined and properties of the CPC were evaluated and compared under in vitro and in vivo conditions. The results indicate that the surface of immersed samples appeared rougher and more porous than that of implanted samples and was covered with a layer of fine apatite crystals. The CPC samples implanted for 4 weeks or longer were surrounded by a layer of fibrous tissue, which was further surrounded by a soft tissue capsule comprising numerous fat cells. The soft tissue capsule had a non-uniform distribution in thickness, which increased most significantly between 4 weeks and 12 weeks after implantation. None of polymorphic cells, osteoblast cells or bone cells adjacent to the implant were observed. The majority of original TTCP powder was transformed into apatite after 1 day of either immersion in Hanks' solution or implantation. The average porosity values of samples immersed in Hanks' solution for 4 weeks or longer were significantly larger than those immersed for 1 day or 1 week. The porosity values of samples implanted for different times were not significantly different. The DTS values of Hanks' solution-immersed samples largely decreased after a few weeks of immersion. The implanted samples maintained their strengths throughout the study.

Citing Articles

Self-setting calcium orthophosphate formulations.

Dorozhkin S J Funct Biomater. 2014; 4(4):209-311.

PMID: 24956191 PMC: 4030932. DOI: 10.3390/jfb4040209.

References
1.
Daculsi G, Passuti N, Martin S, Deudon C, LeGeros R, Raher S . Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological study. J Biomed Mater Res. 1990; 24(3):379-96. DOI: 10.1002/jbm.820240309. View

2.
Ohura K, Bohner M, Hardouin P, Lemaitre J, Pasquier G, Flautre B . Resorption of, and bone formation from, new beta-tricalcium phosphate-monocalcium phosphate cements: an in vivo study. J Biomed Mater Res. 1996; 30(2):193-200. DOI: 10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M. View

3.
Sarda S, Fernandez E, Nilsson M, Balcells M, Planell J . Kinetic study of citric acid influence on calcium phosphate bone cements as water-reducing agent. J Biomed Mater Res. 2002; 61(4):653-9. DOI: 10.1002/jbm.10264. View

4.
Chen W, Ju C, Chern Lin J . Variation in structure and properties of a non-dispersive TTCP/DCPA-derived CPC immersed in Hanks' solution. J Oral Rehabil. 2007; 34(7):541-51. DOI: 10.1111/j.1365-2842.2003.01207.x. View

5.
Schliephake H, Gruber R, Dard M, Wenz R, Scholz S . Repair of calvarial defects in rats by prefabricated hydroxyapatite cement implants. J Biomed Mater Res A. 2004; 69(3):382-90. DOI: 10.1002/jbm.a.20121. View